These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

907 related articles for article (PubMed ID: 14498832)

  • 1. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
    Charest A; Wagner J; Kwan M; Tremblay ML
    Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells.
    Wang Y; Ripperger J; Fey GH; Samols D; Kordula T; Wetzler M; Van Etten RA; Baumann H
    Hepatology; 1999 Sep; 30(3):682-97. PubMed ID: 10462375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.
    Rozakis-Adcock M; Fernley R; Wade J; Pawson T; Bowtell D
    Nature; 1993 May; 363(6424):83-5. PubMed ID: 8479540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grb2 negatively regulates epidermal growth factor-induced phospholipase C-gamma1 activity through the direct interaction with tyrosine-phosphorylated phospholipase C-gamma1.
    Choi JH; Hong WP; Yun S; Kim HS; Lee JR; Park JB; Bae YS; Ryu SH; Suh PG
    Cell Signal; 2005 Oct; 17(10):1289-99. PubMed ID: 16038803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2.
    Pei Z; Maloney JA; Yang L; Williamson JR
    Arch Biochem Biophys; 1997 Sep; 345(1):103-10. PubMed ID: 9281317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
    Zhong H; Minneman KP
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
    Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
    Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes.
    Quadros MR; Peruzzi F; Kari C; Rodeck U
    Cancer Res; 2004 Jun; 64(11):3934-9. PubMed ID: 15173005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
    Vogel W; Ullrich A
    Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
    Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
    Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor induces hypertrophic responses and Stat5 activation in rat ventricular cardiomyocytes.
    Rebsamen MC; Arrighi JF; Juge-Aubry CE; Vallotton MB; Lang U
    J Mol Cell Cardiol; 2000 Apr; 32(4):599-610. PubMed ID: 10756117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
    Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
    J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin.
    Gunaje JJ; Bhat GJ
    Biochem Biophys Res Commun; 2001 Oct; 288(1):252-7. PubMed ID: 11594781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells.
    Ogata A; Chauhan D; Urashima M; Teoh G; Treon SP; Anderson KC
    Clin Cancer Res; 1997 Jun; 3(6):1017-22. PubMed ID: 9815779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.